December 21, 2016 / 10:24 AM / 7 months ago

BRIEF-Almirall signs deal with Mercachem to develop inflammatory skin disease treatment

1 Min Read

Dec 21 (Reuters) - Almirall SA :

* Signs exclusive collaboration deal with Mercachem for the development of oral cytokine blockers for the treatment of inflammatory skin diseases

* Mercachem will receive a down payment of 1 million euros ($1.04 million) and is entitled to milestone payments of 5.5 million euros Source text for Eikon:

Further company coverage: ($1 = 0.9621 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below